Compound Detail
CHEMBL1237021
LURASIDONE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1C[C@@H]1CCCC[C@H]1CN1CCN(c2nsc3ccccc23)CC1
Basic Information
| ChEMBL ID | CHEMBL1237021 |
| Name | LURASIDONE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | PQXKDMSYBGKCJA-CVTJIBDQSA-N |
| Therapeutic | ✓ Yes |
7
Targets
9
Activities
2
Assay Types
0
PK Parameters
20
Publications
3
Known Names
8
Indications
Molecular Properties
492.7
MW (Da)
4.26
ALogP
6
HBA
0
HBD
56.8
PSA (Ų)
0.58
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2010 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Indications
Autistic Disorder Bipolar Disorder Bipolar Disorder Depressive Disorder Depressive Disorder, Major Psychotic Disorders Psychotic Disorders Schizophrenia
ATC Classification
N05AE05
lurasidone
Level 1: NERVOUS SYSTEM
Level 2: PSYCHOLEPTICS
Activity Summary
Ki 8 meas. best 9.3
IC50 1 meas. best 7.8
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| 5-hydroxytryptamine receptor 7 CHEMBL3155 | Ki | 9.3 | 9.3 | 0.5 | 2 |
| D(2) dopamine receptor CHEMBL339 | Ki | 8.78 | 8.78 | 1.7 | 1 |
| D(2) dopamine receptor CHEMBL217 | Ki | 8.77 | 8.77 | 1.7 | 1 |
| 5-hydroxytryptamine receptor 2A CHEMBL224 | Ki | 8.7 | 8.7 | 2.0 | 1 |
| 5-hydroxytryptamine receptor 2A CHEMBL322 | Ki | 8.69 | 8.69 | 2.0 | 1 |
| 5-hydroxytryptamine receptor 1A CHEMBL214 | Ki | 8.17 | 8.17 | 6.7 | 1 |
| 5-hydroxytryptamine receptor 1A CHEMBL273 | Ki | 8.17 | 8.17 | 6.8 | 1 |
| 5-hydroxytryptamine receptor 7 CHEMBL3155 | IC50 | 7.8 | 7.8 | 15.7 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 37468498 | 10.1038/s41467-023-40064-9 | Thromboxane A2 receptor | 4 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 1A | 4 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-2A adrenergic receptor | 4 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M2 | 4 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-1A adrenergic receptor | 4 |
| 37468498 | 10.1038/s41467-023-40064-9 | D(1A) dopamine receptor | 4 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2B | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M1 | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Estrogen receptor | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Progesterone receptor | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Prostaglandin G/H synthase 1 | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Sodium-dependent dopamine transporter | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Peroxisome proliferator-activated receptor gamma | 2 |
| 33582388 | 10.1016/j.ejmech.2021.113243 | 5-hydroxytryptamine receptor 7 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Mu-type opioid receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Vascular endothelial growth factor receptor 2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | D(3) dopamine receptor | 2 |
Data from ChEMBL 36 via Core Engine